Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, Emily Figueiredo Neves Yuki, Tatiana do Nascimento Pedrosa, Solange Fusco, Priscila Tagliaferro Rojo, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Danieli Andrade, Percival D. Sampaio‐Barros, Carolina Torres Ribeiro, Giordano B. H. Deveza, Victor A. O. Martins, Clóvis A. Silva, Marta Heloísa Lopes, Alberto J. S. Duarte, Leila Antonângelo, Éster Cerdeira Sabino, Esper G. Kallás, Sandra Gofinet Pasoto, Eloísa Bonfá